Allergen Data Collection - Update: Cow's Milk (Bos domesticus)
Internet Symposium on Food Allergens 4(1): 19-106 (2002) [http://www.food-allergens.de]

5 Therapy of Cow's Milk Allergy

[Elimination Diets] [Medication] [Oral Desensitization]
 
Elimination Diets Outcome References
Elimination Diet
173 mainly adults with food allergy
Strict elimination diet: some 2/3 reported after 3-5 years that a strict elimination diet had to be followed, otherwise prompt relapse of allergic symptoms was noted. About 1/3 of patients, mainly with milk, cheese or egg allergy, show spontaneous desensitization by appropriate diet (case history, RAST) Wüthrich & Hofer 1986
Elimination Diet
148 children with CMA (age of <1 year)
All cases improved on a milk free diet, in 18% a further modification of the diet was required after the first prescription Ventura & Greco 1988
Elimination Diet
70 children with cow's milk protein intolerance (mean age 30 days)
Remission of symptoms (severe colic) in 71% after elimination of cow's milk protein from the diet; successive challenges caused the return of symptoms in all infants Iacono et al. 1991
Elimination Diet, Nutritional Status
19 children with CMA (age of 0.6 to 4.1 years)
Nutritional status of children was followed during an elimination diet (2 children soy- based formula, other children other foodstuffs and supplementary calcium):
significant reduction in serum prealbumin values; low serum zinc
values in 12 children; low serum iron in 2 children; 2 had high
serum alkaline phosphatase values; dietary intake of energy below recommendation in some children; protein intake high; low intakes of riboflavin in some children
Paganus et al. 1992
Elimination Diet, Calcium
a 4 year old boy with CMA
Calcium deficiency rickets caused by prolonged elimination diet of cow's milk; adequate intake of calcium resulted in rapid improvement Davidovits et al. 1993
Elimination Diet
infants  with CMA
Clinical disappearance of symptoms after removal of milk from the mother's diet and/or elimination from the child's diet, 
significant correlation between alterations of intestinal permeability and ingestion of reputedly hypoallergenic foods, breast milk, and hydrolyzed protein formulas
Barau & Dupont 1994
Elimination Diet, Growth
100 children (mean age 7 months) with atopic dermatitis and challenge- proven CMA
Mean length SD score and weight-for-length index of patients decreased compared with healthy controls; low serum albumin in 6% of patients, 24% had an abnormal urea concentration, and low serum phospholipid docosahexaenoic acid in 8%; delay in growth more pronounced in subgroup of patients with early onset of symptoms Isolauri et al. 1998
Proposed Diet
in case of CMA
Avoidance of all products containing milk, milk protein, lactoprotein, lactoserum protein, CAS, caseinate, lactalbumin, lactose, margarine, cream (contains a list of "allowed" and "prohibited" foods) Moneret-Vautrin 1999

 
 
Medication* Outcome References
Terfenadine / TNF-alpha
children with CMA
In vitro stimulation of PBMC with milk proteins (beta-LG, alpha-LA and CAS) with or without terfenadine: dose- dependent decrease in TNF-alpha secretion in the presence of terfenadine Benlounes et al. 1997
Treatment with DSCG
8 children with CMA
Food challenge before and after a seven- day pre- treatment period with oral sodium chromoglycate: Full protection in 6 children (asthmatic symptoms persisted in 2 patients) Businco et al. 1983a
Treatment with DSCG
7-year-old child experienced acute, severe anaphylaxis after ingestion of cow's milk
After 3 months of oral cromolyn therapy, the patient was able to tolerate small amounts of milk and moderate amounts of foods containing milk Jones 1985
Treatment with DSCG
16 children with CMA
Pretreatment with sodium cromoglycate diminished the effect of milk challenge on gastrointestinal permeability, and usually decreased the severity of elicited symptoms  Falth-Magnusson et al. 1986
Treatment with DSCG
30 children with suspected CMA, a) with clinically positive challenge, b) with negative challenge 
Oral disodiumcromoglycate (DSCG) pretreatment did not alter the number of clinically positive challenges; significant increase in urinary lactose/mannitol ratio (intestinal
permeability test) with placebo pretreatment as compared b); no significant differences after DSCG pretreatment
Van Elburg et al. 1993
Treatment with Ketotifen
1 patient with CMA
White blood cells were pretreated with Ketotifen: inhibition of eosinophils degranulation Podleski et al. 1984
Anti-Idiotypic Antibodies (In Vitro Study)
2 sera from patients with CMA
Concept of specific immune treatment by antibodies capable of specifically neutralizing anti-allergen antibodies;  polyclonal antibodies against a peptide that is complementary to a major epitope of beta-LG were produced; these antibodies neutralized in vitro both well-characterized anti-beta-LG monoclonal antibodies from mice sensitized to beta-LG and anti-beta-LG IgE from 2 patients with CMA Sélo et al. 2002
* Studies may be experimental, unproved, or controversial. Please notice the disclaimer !
 
Oral Desensitization* Outcome References
Oral Desensitization
2 cow's milk and cheese allergic adults
Effective oral desensitization with milk or CAS extracts (desensitization protocol) Wüthrich & Hofer 1986
Oral Desensitization
16 female patients with IgE-mediated CMA (study period 1980-95)
Complete milk tolerance was achieved after a treatment period of 3-5 years in 50% of patients (partial tolerance in 25%), in the other 25% desensitization was interrupted due to repeated allergic reactions during treatment.
Desensitization protocol: starting dose established by SPT end point titration with milk diluted in water; oral desensitization starts with one drop given sublingually; dose increased daily up to 10 mL within 24 days; then the next dilution was given and so on until 250 mL undiluted milk were reached; maintenance dose of at least 1 dL of milk per day
Wüthrich 1996
Oral Desensitization
6 children with CMA (age 4-11 years)
Diluted milk followed by increased pure milk was administered following a standardized protocol, at the beginning pretreatment with oral sodium cromoglycate, length of therapy 5 months, after therapy milk was tolerated (maintenance dose: 100 mL 2-3 times / week); 4 patients finished oral desentization successfully, 2 dropped Patriarca et al. 1998
Oral Desensitization
24 patients with CMA (age 3-43 years)
Treatment was sucessfully completed in 3-8 months in 16 cases; in 5 cases it was abandoned by the patients while in 3 cases the physicians decided to stop (same desensitization protocol as Patriarca et al. 1998) Nucera et al. 2000a
Oral Desensitization
1 patient with CMA (age 6 years)
Desensitization accomplished in 4 month (same protocol as Patriarca et al. 1998);  SPT at the beginning positive for milk, CAS, alpha-LA and beta-LG turned negative after 7 months; specific IgE against milk proteins decreased, while specific IgG4 and IgA increased; reduced production of IL-4 both in vitro (stimulated mononuclear blood cells) and in serum; increased production of IFN-gamma by T-lymphocytes (both spontaneously and after stimulation with beta-LG); results indicating  a switch from a Th2 response (production of IL-4) to a Th1 response (with production of IFN-gamma) during oral desensitization Nucera et al. 2000b
Oral Desensitization
12-year-old girl with persistent IgE-CMA
Effective oral desensitization starting with diluted milk (under clinical conditions, 4-6 doses per day) for 5 days, maintenance with daily intake of fresh milk Bauer et al. 1999
Oral Tolerization
a) 10 infants fed cow's milk- based formula
b) 10 infants fed a CAS hydrolysate formula until the age of 9 months
Exposure to cow's milk proteins after the age of 9 months resulted in depressed cellular and humoral responsiveness (beta-LG, BSA, CAS specific IgG and PBMC proliferation) Vaarala et al. 1995
* Studies may be experimental, unproved, or controversial. Please notice the disclaimer !
 

6 Composition of Cow's Milk
 

7 Allergens of Cow's Milk
 
Proteins / Glycoproteins Allergen Nomenclature References
alpha-Lactalbumin [14.2 kDa] Bos d 4 Goldman et al. 1963a, Gjesing et al. 1986
beta-Lactoglobulin [18.3 kDa] Bos d 5 Goldman et al. 1963a, Gjesing et al. 1986
Serum Albumin [67 kDa] Bos d 6 Goldman et al. 1963a, Gjesing et al. 1986
Immunoglobulin [160 kDa] Bos d 7 Gjesing & Lowenstein 1984, Gjesing et al. 1986, Bernhisel-Broadbent et al. 1991
Caseins [20-30 kDa] Bos d 8 Goldman et al. 1963a, Gjesing et al. 1986, Docena et al. 1996
Lactoferrin [80 kDa]   Wal et al. 1995a

7.1 Sensitization to Cow's Milk Allergens
 
Country / Subjects Sensitivity to References
Argentina, La Plata
80 patients with CMA (3 months to 25 years, mean 6 years)
CAS in 100%
beta-LG in 13%
alpha-LA in 6.3%
(SDS-PAGE immunoblot, RAST)
Docena et al. 1996
Australia, North Ryde, NSW
children with immediate-type CMA
beta-LG in 63%
alpha-LA in 75%
(RAST)
Adams et al. 1991
Denmark, Odense
a) 21 infants with IgE-CMA
b) 18 infants with non-IgE-CMA
  (a)   (b)  
beta-LG 50% (45%) 20% (76%)
alpha-LA 6% (25%) 7% (6%)
BSA 63% (75%) 27% (88%)
bovine IgG 19% (40%) 0% (59%)
Lactoferrin 0% (25%) 7% (0%)
at 6 months (12 months)
(specific serum IgE in CRIE after milk challenge)
Host et al. 1992
Finland, Turku
challenge proven patients with CMA (age of <17 years) (n=11 in SPT, n=12 in RAST)
  SPT RAST (>/= 2)
alpha-CAS 91% 25%
alpha-LA 82% 67%
beta-LG 64% 50%
BSA 73% 25%
Vanto et al. 1987
France, Lille, Gif sur Yvette
92 patients with CMA
  (1) (3)
beta-LG in 61% 68%
CAS  in 65% 66%
alpha-LA  in 51% 58%
BSA  in 43% 50%
colostral IgG    36% (2)
Lactoferrin  in 35% 45%
(RAST)
Association of sensitivities (1):
CAS in 87% of alpha-LA sensitive patients
beta-LG in 78% of alpha-LA sensitive patients
BSA sensitivity seemed independent
Lactoferrin negative correlation to CAS
(1) Wal et al. 1995a
(2) Lefranc-Millot et al. 1996
(3) Bernard et al. 1998
Germany, Kiel
13 children with strongly suspected CMA (age of 8 months to 8 years)
alpha-LA in 85%
beta-LG B in 77%
beta-LG A in 69%
CAS in 69%
alpha-S CAS  in 46%
beta-CAS  in 62%
kappa-CAS  in 54%
(SPT)
Kaiser et al. 1990
Italy, Milan
6 children with CMA
alpha-CAS  100%
beta + gamma-CAS  50%
kappa-CAS  33%
alpha-LA 17%
beta-LG 50%
BSA 0%
(according to graded staining in SDS-PAGE immunoblot)
Restani et al. 1999
Italy, Rome
25 children with CMA (DBPCFC)
CAS (23-36 kDa) 72%
alpha-LA (14.2 kDa) 72%
beta-LG (18.3 kDa) 72%
BSA (66 kDa) 72%
Lactoferrin (80 kDa) 28%
(SDS-PAGE immunoblot)
Businco et al. 2000
Japan, Tokyo
8 children with CMA
CAS 75% (RAST) Hasegawa et al. 2000
Switzerland, Geneva
10 children with CMA
CAS 90%
alpha-LA 20%
beta-LG 50%
(SDS-PAGE immunoblot)
Szabó & Eigenmann 2000
Switzerland, Zurich
(1) 34 adults with CMA
(2) 8 adults with CMA
  (1) (2)
CAS in 71% in 100%
beta-LG in 3% in 13%
alpha-LA in 15% in 0%
(RAST)
(1) Stoger & Wüthrich 1993
(2) Wüthrich & Johansson 1995
Taiwan, Taipei
30 children with suspected CMA (1 to 9 years of age)
CAS in 80%
beta-LG in 53%
alpha-LA in 80%
(RAST)
multiple sensitization to 
alpha-LA and beta-LG in 13%
CAS and alpha-LA in 27%
CAS, alpha-LA and beta-LG in 37%
Lin et al 1998
USA, Baltimore, MD
22 cow's milk- sensitive patients
bovine Immunoglobulins in 73% (RAST) Bernhisel-Broadbent et al. 1991
USA, Galveston, TX
45 children with CMA (96% < 6 months of age)
  Skin Test n= OCT* n=
alpha-LA in 53% 34 in 50% 20
beta-LG in 62% 37 in 52% 23
BSA in 52% 44 in 42% 26
CAS in 60% 45 in 63% 27
*frequencies in 27 oral challenge test (OCT) positive children
(1) Goldman et al. 1963a
(2) Goldman et al. 1963b
USA, Rochester, NY
(1) 29 children with CMA (age of onset 1 day to 10 months)
(2) 21 children with CMA
  RAST (>/= 3) n= IB*
alpha-LA in 71% 24 in 4.8%
beta-LG in 54% 24 in 14%
BSA     in 14%
CAS in 46% 26 in 57%
Reference (1)   (2)
*SDS-PAGE immunoblot (graded scale >/= 2+)
(1) Schwartz et al. 1987
(2) Amonette et al. 1993

7.2 alpha-Lactalbumin
7.3 beta-Lactoglobulin
7.4 Bovine Serum Albumin
7.5 Caseins

8 Isolation & Preparation
 
Extract / Purified Allergens Methods References
CAS and whey proteins Review of purification and analytical methods by chromatography and electrophoresis methods Strange et al. 1993
alpha CAS Purification of commercial CAS by IEC (DEAE Sepharose) Spuergin et al. 1996
Spuergin et al. 1997
alpha S1-, alpha S2-, beta-, and kappa- CAS Isoelectric precipitation of whole CAS from skimmed raw milk at pH 4.6; isolation of CAS fractions by successive, selective precipitations, followed by dissolving, dialysis and freeze drying steps; further purification by IEC (purity assessed by RP-HPLC) Bernard et al. 1998
glycosylated and non-glycosylated alpha-LA fractions Isolation from whey protein fraction by IEC (DEAE Sepharose) followed by SEC (Sephadex G-75) Slangen & Visser 1999
beta-LG Preparation from milk (1); purification by affinity chromatography (antibovine IgG column) followed by IEC (Q Sepharose), purity assessed by RP-HPLC and SDS-PAGE (2) (1) Wal et al. 1995b
(2) Selo et al. 1999
bovine IgG Acid precipitation of colostral whey and concentration of supernatant, isolation of IgG by affinity chromatography (Avid Gel AL) and further purification by IEC, dialysis, lyophylization Lefranc-Millot et al. 1996

 

9 Cross-Reactivities
 
Cross-Reacting Allergens Subjects / Methods References
Cow's Milk Allergens
cow's dander allergens
6 patients with cow's milk and 5 with cow's dander allergy:
4/6 patients with CMA showed serum IgE binding to dander allergens of 20, 22, 36, 50 and >200 kDa, dander cross- reactive cow's milk allergens were CAS (2 cases) and beta-LG (1 case); 1/5 cow's dander allergic patients showed serum IgE binding to milk allergens of 69, 92 and >200 kDa (immunoblot inhibition)
Szepfalusi et al. 1993
Cow's Milk
goat's, sheep, and modified cow's milk formulas
16 children with CMA: high inhibition of IgE- binding to cow's milk by goats', sheep, modified cows' milk formula and CAS formula (RAST inhibition) Dean et al. 1993
Cow's Milk
goat's milk
9 milk allergic patients: IgE- binding to cow's and goat's milk proteins corresponding in Mr to beta-LG and CAS (immunoblot) Sabbah et al. 1996
Cow's Milk
beef*
8/11 beef allergic children presented concomitant reactivity to cow's milk (DBPCFC)* Werfel et al. 1997a
Cow's Milk
bovine IgG (160 kDa) from beef
Complete inhibition of IgE-binding to bovine IgG from beef by cow's milk (immunoblot inhibition, pooled serum from 5 beef allergic patients) Ayuso et al. 2000
Cow's Milk
goat's milk
26 children with CMA (DBPCFC positive);
Sensitivity to goat's milk in 92% (DBPCFC); cow's milk completely extinguished IgE- binding to goat's milk allergens, goat's milk partially inhibited IgE- binding to cow's milk allergens (SDS-PAGE inhibition)
Bellioni-Businco et al. 1999
Cow's Milk
ewe, goat, buffalo milk
6 children with CMA:
IgE- binding to milk allergens from cow, ewe, goat, and buffalo, but not from camel  (SDS-PAGE immunoblot, inhibition)
Restani et al. 1999
Cow's Milk
mare's milk
3 children with CMA:
Up to 28% inhibition of IgE- binding to cow's milk allergens (CAS, alpha-LA, beta-LG, BSA, and lactoferrin) by mare's milk extract  (SDS-PAGE immunoblot inhibition, densitometry)
Businco et al. 2000
alpha-LA
lysozyme (hen's egg white)
6/9 egg allergic patients: 12-49% Inhibition of IgE- binding to lysozyme by alpha-LA (RAST inhibition) Walsh et al. 1987
Caseins
goat's, sheep's, and cow's milk
Inhibition of IgE- binding to goat's and sheep's CAS by cow's milk CAS in 1 adult (RAST inhibition) Wüthrich & Johansson 1995
Caseins
whole casein fractions from cow, goat, ewe, rabbit and rat milk *
Sera from 58 patients with CMA and specific IgE to bovine CAS:
specific IgE titers:
bovine > ovine > caprine CAS;
79% and 66% of sera showed IgE-binding to rabbit-CAS and rat-CAS of <10% intensity as compared to bovine CAS (ELISA)
Bernard et al. 1999
alpha Caseins
goat's, sheep's, and cow's milk
17 children with CMA (immediate type): Inhibition of IgE binding to bovine alpha-CAS by alpha-CAS from cow, goat, and sheep (RAST inhibition), lower specific IgE levels to goat- and sheep alpha-CAS (RAST) Spuergin et al. 1997
Cow's Milk
human milk
Exclusively breast-fed children with atopic dermatitis: cross- reactivity between lactoferrin, serum albumin, beta-CAS, and alpha-LA from human and cow's milk, no specific IgE against bovine beta-LG; no clinical relevance of human milk proteins Cantisani et al. 1997
Bertino et al. 2000
Cow's Milk
beta-CAS from cow's milk and human milk
20 patients with CMA and specific IgE against bovine whole CAS: 7 sera contained IgE specific for human beta-CAS; inhibition studies using native human and bovine beta-CAS as well as bovine beta-CAS-derived peptides (aa 53-139, aa 106-209, and aa 1-52) demonstrated several common epitopes (ELISA) Bernard et al. 2000b
*  multiple sensitization (not proved by inhibition-tests)
 
 
Unique Allergens Subjects / Methods References
Caseins
goat's and sheep's vs cow's milk CAS
No inhibition of IgE- binding to goat's and sheep's CAS by cow's milk CAS in 1 adult (RAST inhibition) Wüthrich & Johansson 1995
Caseins
goat's and sheep's vs cow's milk CAS
1 cow's milk tolerant child with goat's and sheep's milk allergy: Decreased inhibition of IgE- binding to goat's milk and CAS by cow's milk and CAS, but not by goat's and sheep's milk and CAS (RAST inhibition); IgE binding to allergens in goat's milk at 22, 27, and 31 kDa, in sheep's milk at 31 kDa and cow's milk at 34 kDa (SDS-PAGE immunoblot) Umpierrez et al. 1999
Cow's and Mare's Milk
16 and 18 kDa allergens (most likely representing alpha-LA and beta-LG) from mare's milk did not cross-react with corresponding cow's milk allergens
1 mare's milk allergic adult (cow's milk tolerant)
(SPT, intracutaneous test, RAST, SDS-PAGE immunoblot)
Gall et al. 1996

10 Stability of Cow's Milk Allergens
 
Treatment Effects References
Heat
boiling of skimmed milk, 10 min
Reduction of IgE binding to alpha-LA about 50%, to CAS fractions >66% and to beta-LG, BSA and bovine Ig binding abolished (CRIE score) Gjesing et al. 1986
Pasteurization, Homogenization, Hydrolysis
1) raw untreated, 2) pasteurized or, 3) homogenized and pasteurized cow's milk, and 4) a commercial hypoallergenic hydrolysed CAS infant formula
Similar positive reactions in SPT and DBPCFC to 1), 2) and 3), no reactions to 4) in 5 cow's milk allergic children (immediate- type); tendency of lower thresholds of processed milk Host & Samuelsson 1988
Heat
boiling of milk, 2 and 10 min
Boiling of milk for 10 but not for 2 min eliminated SPT reactivity to BSA and beta-LG, whereas CAS was heat stabile (8 DBPCFC positive adults with CMA) Norgaard et al. 1996
Heat
boiling of milk, 5 min
No difference in IgE- binding to raw and cooked milk from sera of 2 patients with CMA (immuno-dot-blotting) Werfel et al. 1997a
Heat
boiling of extensively hydrolyzed CAS formula (Nutramigen)
Positive SPT to boiled and unboiled formula in a girl with CMA Nilsson et al. 1999
Heat, Reduction, Hydrolysis
a) heat 96°C, pH 8.0
b) carboxymethylation
c) limited proteolysis
Thermoaggregated (a) and reduced forms (b) exhibited similar
anaphylactic effect on sensitized guinea pigs; allergenic properties of beta-LG appeared unaltered in food hydrolyzates after thermal treatment and limited proteolysis
Gmoshinskii et al. 1990
gamma Irradition
alpha-CAS, beta-LG
ELISA inhibition using patients' IgE and rabbit IgGs specific for alpha-CAS and beta-LG, respectively: reduced IgE-binding to irradiated proteins with different slopes of inhibition curves; rabbit IgG-binding increased up to a certain dose of irradiation and then decreased; main bands disappeared in SDS-PAGE  with increasing doses while turbidity increased indicating a decrease of solubility (20 patients with CMA) Lee et al. 2001
Pepsin Hydrolysis, Pancreatic Enzymes, Whey Proteins
hydrolysis with pepsin (pH 2, 3, and 4, for 90 min) followed by hydrolysis with a mixture of pancreatic enzymes (pH 7.5 for 150 min) of beta-LG, alpha-LA, BSA, and bovine IgG
Percent inhibition of IgE-binding from sera of patients with IgE- mediated CMA to native proteins by respective hydrolysates of homologue protein:
pepsin hydrolysis at pH 2 pH 3 pH 4
beta-LG* 8% 0% 0%
alpha-LA 5% 14% 48%
BSA 0% 0% 58%
bovine IgG 2.5% 54% 91%
(RAST inhibition)
* beta-LG is barely hydrolysed by pepsin, but susceptible to pancreatic enzymes
Schmidt et al. 1995
Duodenal Digestion
in vitro digestion of cow's milk proteins by duodenal fluid (1) and human trypsins and elastases (2)
Rate of hydrolysis:
purified proteins > crude cow's milk or formula;
rates of alpha-LA, beta-LG, and CAS digestion were 0.03, 0.12, and 16.1 mg/mL duodenal juice/min (same capacity to hydrolyze the milk proteins in infants with CMPI, celiac disease, or unclassified gastrointestinal disorder) 
(1) Jakobsson et al. 1982
(2) Jakobsson et al. 1983
Intestinal Digestion
intestinal digestion of beta-LG, alpha-LA and CAS (intestinal cells, 48h)
Lower TNF-alpha production by stimulation of PBMC from cow's milk allergic patients with intestinal digested cow's milk proteins as compared to intact proteins Benlounes et al. 1996
Cell-Envelop Proteinase
specific hydrolysis of CAS and ultrafiltration
Elimination of IgE-binding epitopes by degradation of CAS and removal of whey proteins by ultrafiltration Alting et al. 1998
Pepsin Hydrolysis, beta-LG
pepsin hydrolysis of beta-LG
222 cow's milk intolerant / allergic patients:
Higher degree of IgG binding to native beta-LG than to pepsin digested LG as compared to controls; almost complete discrimination between patient groups by cross- reactive experiments (ELISA)
Duchateau et al. 1998
Lactic Acid Fermentation
lactic acid fermentation of sterilized cow's milk with a mixed culture of meso- and thermophilic bacteria strains
About 99% reduced antigenicity of whey proteins as compared to raw milk (rabbit pAb, ELISA); allergenicity of alpha-LA and beta-LG only slightly attenuated (Skin Tests) Jedrychowski & Wroblewska 1999

11 Allergen Sources
 
Reported Adverse Reactions References
Human Milk
Cow's milk taken by the mother precipitated allergic symptoms in 61 breast fed infants (elimination/challenge in mother's diet) (1)
Proctocolitis triggered by cows' milk protein transferred to 11 infants via the breast milk; resolution of visible rectal bleeding within 72 to 96 hours after elimination of cow's milk from mother's diet (colonoscopy performed in 5 infants revealed benign eosinophilic proctocolitis) (2)
(1) Gerrard & Shenassa 1983a, 1983b
(2) Pumberger et al. 2001
"Non-dairy" Foods
Allergic reactions in 6 patients with CMA after ingestion of "non-dairy" products: tofu frozen dessert (2 cases), beef hot dog (2 cases), bologna (2 cases), rice frozen dessert, tuna packed in aqueous solution; contents of milk proteins due to contamination by manufacturing facilities (37-2202 µg/mL) or to unlabeled adding of caseinate (136 µg/mL) (1)
(1) Gern et al. 1991
Cake, Cookie, Pastry
Near-fatal anaphylactic reactions in 2 children with CMA (age of 9 and 12 years) after ingestion of a cookie, a cake or pastry containing the allergen (1)
(1) Sampson et al. 1992
Chocolate, Candy
Occupational asthma and rhinoconjunctivitis in a chocolate candy worker (positive conjunctival and bronchial challenge tests with lactalbumin) (1)
(1) Bernaola et al. 1994
Several Food Products
9 Adverse reactions to unexpected cow's milk allergens in
a) Meatballs containing 1.1% CAS (undeclared)
b) Hot dog containing 0.04% CAS (contaminated)
c) Recombined ham containing 2.6% (undeclared)
d) Sausage containing 1.0% CAS (undeclared)
e) Sausage containing 0.06% CAS (contaminated)
f) Dark chocolate containing 0.8% CAS (contaminated)
g) Ice cream (soy based) containing 0.2% CAS (contaminated)
h) Lollipop, strawberry / cream containing 0.2% CAS (undeclared)
i) Meringue containing 1.1% CAS (undeclared)
Malmheden Yman et al. 1994
Sorbets
Frozen desserts manufactured using the same equipment used for producing ice cream may contain milk allergens:
Anaphylaxis in a 2-year-old boy after ingestion of a "pareve"- labeled raspberry sorbet (kosher labeling to select dairy-free foods) (1)
Anaphylaxis in a 3-year-old boy within 20 min after ingestion of a lemon sorbet (ca. 113 to 170 g) containing trace amounts of milk allergens (whey proteins: 9 µg/mL)  (2) 
(1) Jones et al. 1992
(2) Laoprasert et al. 1998
Sausage
Severe reactions after ingestion of sausage containing CAS (texturing agent) (1)
(1) Foucard et al. 1997
Cheese
Anaphylaxis after ingestion of cheese in a 23-year old woman (1)
(1) Wüthrich & Hofer 1986
Goat's and Sheep's Cheese
Several allergic reactions after ingestion of feta (cheese made from sheep's milk) in a 15-year-old boy, after ingestion of sheep's or goat's cheese in a 25-year old patient, both tolerated ingestion of diary procucts from cow's milk  (1)
Allergic reactions after eating goat's cheese and after touching of goat's and sheep's cheese in a 2-year-old girl with tolerance to dairy products from cow's milk (2)
(1) Wüthrich & Johansson 1995
(2) Umpierrez et al. 1999
Sheep's Cheese
Several anaphylactic reactions after ingestion of food containing "pecorino" cheese made from sheep's milk in a 5-year-old atopic boy unaffected by cow's milk protein allergy (1)
(1) Calvani & Alessandri 1998
Mozarella / Ricotta / Parmesan Cheese
Asthma, urticaria and rhinitis in a boy with atopic dermatitis after ingestion of mozarella cheese made from ewe's and cow's milk; several allergic reactions after ingestion of ricotta cheese containing ewe's milk and parmesan cheese made from cow's milk, respectively (1)
(1) Fiocchi et al. 1999
Baby Food
A baby food, cereal flour P, containing alpha- lactalbumin (although labeled guaranteed free of cow's milk), caused failure to thrive and diarrhea, vomiting, and coughing fits in a 22- month- old child with cow's milk allergy (1)
(1) Fremont et al. 1996
Casein in Salmon
A 30 year-old woman with CMA (without fish sensitivity) experienced anaphylaxis within 1 hour after ingestion of a slice of bread with salmon, prepacked from a supermarket, the salmon meat was restructured by microbial enzyme (transglutaminase) which crosslinks added CAS and meat proteins, assuming a consumption of 10 to 50 g salmon, about 10 to 50 mg CAS were ingested (1)
(1) Koppelman et al. 1999
Casein-containing Product
A 25-year-old with asthmatic symptoms which were work-related to the production process of candy making due to inhalation of Hyfoama DS (bronchial challenge, SPT, RAST); Hyfoama DS is a colorless, water-soluble powder produced from CAS treated with calcium hydroxide solution and then dried. It is used as a substitute for egg white in a variety of baked goods. The manufacturer recommends labeling of the final product as containing “hydrolyzed milk protein.”
(1) Bader et al. 2001
Casein in Tryptone Powder
Adult-onset sensitization to CAS in a 44-year-old male scientist after occupational exposure to aerosolized tryptone powder (CAS product used in preparation of culture media); subsequent systemic allergic reaction after ingestion of milk containing candy (SPT)
(1) Vaswani et al. 1999
Human Milk
16/17 of cow's milk allergic children showed allergic symptoms during cow's milk challenge through human milk from asymptomatic mothers (age of children 1.8 to 9.4 months)
(1) Jarvinen et al. 1999b
Infant Formulas see 12.2 Allergenicity / Safety of Infant Formulas
Pharmaceuticals
Anaphylaxis in a 12 months-old boy after cutaneous application of a CAS containing ointment to an inflamed diaper area (1)
Severe anaphylactic reaction in a 33-year-old woman during artificial insemination due to sperm- processing medium containing BSA (SPT, RAST) (2)
Generalized anaphylactic reaction a few hours after tooth extraction in a 54-year-old woman, hemofibrine (a hemostatic sponge made of bovine fibrin) elicited symptoms (Scratch test, RAST) (3)
3 out of 6 patients with positive RAST against CAS experienced allergic symptoms after taking antibiotics containing CAS (4)
(1) Jarmoc & Primack 1987
(2) Wüthrich et al. 1995
(3) Wüthrich et al. 1996
(4) Hasegawa et al. 2000
"Neutralizing" of Food Allergies
68-year-old woman with systemic mastocytosis  was given "neutralizing" injections of milk and wheat and experienced flushing, palpitations, and lightheadedness with syncope (unproven technique of provocation/neutralization) (1)
(1) Teuber & Vogt 1999

 
Allergens in Products Content / Products References
Human Milk
38 mothers
Detectable amounts of immunoactive beta-LG (5-33 ng/mL) in 18/38 human milk samples Jakobsson et al. 1985
Human Milk
25 mothers
Detectable amounts of beta-LG (5-800 ng/mL) in 40%of human milk samples, presence of symptoms in the infant such as diarrhoea, vomiting, colic, exanthema significantly correlated to high levels of beta-LG in the milk Axelsson et al. 1986
Human Milk
57 breastfeeding mothers
Detectable amounts of bovine beta-LG (up to 6.4 ng/mL) in 45% of samples; persisted up to 3 days after maternal dietary elimination of cow's milk Machtinger & Moss 1986
Human Milk
9 breastfeeding mothers
Detectable amounts of bovine beta-LG (0.5-45 ng/mL) in 30% of samples Host et al.1988
Human Milk
36 samples of human breast milk
Detectable amounts of bovine IgG (mean 3.4 ng/ml) Maeda et al. 1993
Human Milk
55 breastfeeding mothers (cow's milk allergy in 46 infants, oral challenge)
beta-LG in human milk before and after oral cow's milk load (given after 24 hour milk free diet): beta-LG levels >2 ng/mL in 75% of samples, increased levels in 50% after load Sorva et al. 1994
Fat Substitutes
13 (16) egg and/or cow's milk allergic patients
Allergenicity of microparticulated egg and cow's milk proteins in fat substitues (Simplesse, Beta IL): No alteration of allergenic potencies in SDS-PAGE immunoblot (1) Sampson & Cooke 1990
(2) Sampson & Cooke 1992
Flavourings / Seasonings
dill-pickle seasoning (containing lactose)
Positive skin test reaction to lactose containing seasoning (1 patient with CMA); CAS and whey proteins identified in this seasoning, and whey proteins in pharmaceutical grade lactose Watson et al. 1995
Lactose
"food-quality" lactose
alpha-LA content in "food quality" lactose 1-5 µg/g (RAST inhibition) Fremont et al. 1996
Natural Rubber Latex Gloves
cow's milk CAS
15/30 commonly marketed natural rubber latex glove brands contained cow's milk CAS (rocket immunoelectrophoresis, ELISA inhibition) Ylitalo et al. 1999

 
Allergen Depleted Products Method References
Cow's Milk
depletion of beta-LG
Specific affinity matrix: beta-LG coupled to Sepharose 4B used to remove beta-LG from milk, significant retardation in its elution because reversible polymerization with soluble beta-LG; beta-LG depleted milk proposed as hyposensitizing milk formula to be used by lactating mothers Chiancone & Gattoni 1993

 
Allergen Free Products Method References
Human Milk
lactating mothers
No detection of beta-LG and bovine CAS in human milk (SDS-PAGE immunoblotting using mAb) Restani et al. 2000

12 Food Allergen Labeling
 
Food Allergen  Labeling / Regulation Status References
International Regulations
Milk and milk products
Mandatory labeling of prepackaged food / advisary status (1) (1) Codex Alimentarius Commission 1999
European Regulations
Milk and milk products
Labeling appropriate / recommendation (1)
Mandatory labeling of prepackaged food / proposal for directive (2)
(1) Bousquet et al. 1998
(2) European Commission 2001

13 Infant Formulas
14 References


copyright © 2000-2002 by matthias besler -  ONLINE PUBLISHER
home: www.food-allergens.de